Dong M, Penin F, Baggetto L G
Insitut de Biologie et Chimie des Protéines, UPR 412 CNRS, 7 Passage du Vercors, F-69367 Lyon Cedex 07, France.
J Biol Chem. 1996 Nov 15;271(46):28875-83. doi: 10.1074/jbc.271.46.28875.
Plasma membrane P-glycoprotein is known as an ATP-dependent drug efflux pump that confers multidrug resistance to tumor cells. None of the reported purification procedures worked properly for our P-glycoprotein-overproducing cell lines, i.e. murine lymphoid leukemia P388/ADR25, rat hepatoma AS30-D/COL10, and human lymphoblastic leukemia CEM/VLB5 cells. We have thus developed a general procedure for efficient purification of P-glycoprotein by combining solubilization with sodium dodecyl sulfate and chromatography on ceramic hydroxyapatite. This procedure was successful for the three cell lines and yielded 70% of the P-glycoprotein present in the starting plasma membranes with more than 99% purity. After exchanging sodium dodecyl sulfate into dodecyl maltoside and reconstitution into liposomes, purified P-glycoprotein exhibited a specific ATPase activity of about 200 nmol/min/mg, which was very similar to that obtained for P-glycoprotein solubilized and purified with 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid. This ATPase activity was sensitive to orthovanadate inhibition and stimulated by verapamil and other drugs. More importantly, drug transport properties of the reconstituted P-glycoprotein were comparable with those of P-glycoprotein embedded in plasma membranes. Since it is virtually devoid of lipids, this preparation is suitable for both functional and structural investigations.
质膜P-糖蛋白是一种依赖ATP的药物外排泵,可赋予肿瘤细胞多药耐药性。对于我们过量表达P-糖蛋白的细胞系,即小鼠淋巴细胞白血病P388/ADR25、大鼠肝癌AS30-D/COL10和人淋巴细胞白血病CEM/VLB5细胞,所报道的纯化方法均无法正常工作。因此,我们开发了一种通用方法,通过将十二烷基硫酸钠增溶与陶瓷羟基磷灰石色谱相结合来高效纯化P-糖蛋白。该方法对这三种细胞系均取得成功,从起始质膜中获得了70%的P-糖蛋白,纯度超过99%。将十二烷基硫酸钠换成十二烷基麦芽糖苷并重新组装成脂质体后,纯化的P-糖蛋白表现出约200 nmol/min/mg的特异性ATP酶活性,这与用3-[(3-胆酰胺丙基)二甲基铵]-1-丙烷磺酸溶解和纯化的P-糖蛋白所获得的活性非常相似。这种ATP酶活性对原钒酸盐抑制敏感,并受维拉帕米和其他药物刺激。更重要的是,重组P-糖蛋白的药物转运特性与质膜中嵌入的P-糖蛋白相当。由于该制剂几乎不含脂质,因此适用于功能和结构研究。